"Personalizing" therapy for non-small cell lung cancer.

Abstract excerpt

The sequencing of the human genome has lead to an even greater understanding of the genetic basis of numerous diseases. During the past several years, genetic approaches to a number of solid organ malignancies, including non-small cell lung cancer, have lead us to an increased understanding of the disrupted genetic pathways involved in tumor initiation and progression. Two recent articles are reviewed that...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Carcinoma, Non-Small-Cell Lung
• Share to Gene Expression Regulation, Neoplastic
• Share to Genomics